, 7580 serum specimens were tested for HBsAg by the passive haemagglutination test, Hepanosticon. Serum from 38 people gave a positive result after absorption with the absorbent provided, but the presence of HBsAg could not be confirmed by other tests. Tests for current infection with EB virus, namely, the presence of heterophil antibody and EB virus specific IgM, were performed and were positive in 11 of the 38. In six of these the clinical picture was of hepatitis rather than infectious mononucleosis.
The Hepanosticon passive haemagglutination test for hepatitis B surface antigen (HBsAg) employs 'stabilised' sheep erythrocytes coated with sheep antibody to HBsAg (anti-HBs). These erythrocytes are 'agglutinated' by sera containing HBsAg (Edwards and McSwiggan, 1974) . This was essentially similar to the indirect immunofluorescence Henle test for IgG (Sumaya et al., 1975) except that the HR-1K cell line was used for antigen, the patient's serum was allowed to react with the antigen for three hours, and, after washing, was stained by a specific anti-human IgM/fluorescein isothiocyanate conjugate made by Wellcome Research Laboratories. When the EB IgM test was found positive but the monospot and heterophil antibody tests were negative, the Rheuma-Wellco test for rheumatoid factor (RF) was used to check for specificity of the reaction. If the RF test was positive the EB IgM test was repeated using only the macroglobulin fraction of the serum after separation on a sucrose density gradient.
Results
Of the 7580 sera tested in 1975 and 1976, 38 (0 5 %) gave a positive Hepanosticon test after one absorption but negative results in IEOP and RIA. 
